Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Department of Anesthesiology, Tianjin Medical University General Hospital, Tianjin, China.
AIDS Res Ther. 2023 Mar 16;20(1):16. doi: 10.1186/s12981-023-00511-5.
The usage of antiretroviral treatment (ART) has considerably decreased the morbidity and mortality related to HIV-1 (human immunodeficiency virus type 1) infection. However, ART is ineffective in eradicating the virus from the persistent cell reservoirs (e.g., microglia), noticeably hindering the cure for HIV-1. Microglia participate in the progression of neuroinflammation, brain aging, and HIV-1-associated neurocognitive disorder (HAND). Some methods have currently been studied as fundamental strategies targeting microglia. The purpose of this study was to comprehend microglia biology and its functions in HIV-1 infection, as well as to look into potential therapeutic approaches targeting microglia.
抗逆转录病毒治疗(ART)的应用大大降低了与 HIV-1(人类免疫缺陷病毒 1 型)感染相关的发病率和死亡率。然而,ART 无法从持续存在的细胞储库(如小胶质细胞)中彻底清除病毒,这明显阻碍了 HIV-1 的治愈。小胶质细胞参与神经炎症、脑衰老和 HIV-1 相关神经认知障碍(HAND)的进展。目前已经有一些方法被研究作为针对小胶质细胞的基本策略。本研究旨在了解小胶质细胞生物学及其在 HIV-1 感染中的作用,并探讨针对小胶质细胞的潜在治疗方法。